SCHEMBL8489586

SCHEMBL8489586

CC(C)N1Cc2cccc(C(=O)O)c2NS1(=O)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA4 P22748 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
HTT P42858 1/20 0.36
ALOX15 P16050 1/20 0.36
PARP1 P09874 1/20 0.35
HRH3 Q9Y5N1 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KCNH2 Q12809 1/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
POLB P06746 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
LIG1 P18858 1/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2603740 0.71 KDM4E (0.47) HRH3KCNH2KDM4EKMT2ARECQL
SCHEMBL31394735 0.69 CA12 (0.44) CA12CA1CA2CA4CA7
SCHEMBL21872073 0.64 PTPN1 (0.41) KDM4EALDH1A1RECQLTDP1
SCHEMBL21527724 0.61 MAP3K5 (0.46) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL5381248 0.61 LIG1 (0.42) CA12CA1CA2CA4CA7
SCHEMBL3243204 0.61 LIG1 (0.42) CA12CA1CA2CA4CA7
Hydrochloric Acid SCHEMBL30075334 0.60 LIG1 (0.41) CA12CA1CA2CA4CA7
SCHEMBL9374810 0.60 AHR (0.56) CA12CA1CA2CA4CA7
SCHEMBL28798325 0.59 ALDH1A1 (0.48) CA12CA1CA2CA4CA7
Phthalic Acid SCHEMBL28418540 0.59 ALDH1A1 (0.78) CA12CA1CA2CA4CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999010346-A1 BENZOTHIADIAZINYL-INDOLE DERIVATIVES AND THEIR USE AS SEROTONIN RECEPTOR LIGANDS ELI LILLY AND COMPANY LIMITED (GB) 1999-03-04 WO disclosed